Values First Advisors »

4d Molecular Therapeutics In shares owned by Values First Advisors

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Values First Advisors from 13F filings

Historical chart of Values First Advisors investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Values First Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Values First Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $58k 5.3k 10.81

More positions owned by Values First Advisors

Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Ishares Tr Core 1 5 Yr Usd (ISTB)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Ensign (ENSG)
Emergent BioSolutions (EBS)
Monolithic Power Systems (MPWR)
Ishares Tr 3 7 Yr Treas Bd (IEI)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Mid-America Apartment (MAA)
National Retail Properties (NNN)
Ishares U S Etf Tr Blackrock Sh Dur (NEAR)
Vaalco Energy Com New (EGY)
LeMaitre Vascular (LMAT)
Alnylam Pharmaceuticals (ALNY)

View all positions for Values First Advisors

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
BlackRock
BlackRock
VR Adviser
Goldman Sachs Group
Deep Track Capital
Henderson Group
Vanguard Group
State Street Corporation
Assenagon Asset Management
Novo A/S
Morgan Stanley
Redmile Group
Braidwell

View all funds holding 4d Molecular Therapeutics In